<DOC>
	<DOCNO>NCT01122056</DOCNO>
	<brief_summary>The purpose study investigate effect tolerability exercise side effect injectable disease modify treatment multiple sclerosis . The investigator main hypothesis control exercise safe well tolerated patient multiple sclerosis improve disease modify treatment related side effect fatigue .</brief_summary>
	<brief_title>Effect Aerobic Exercise Side Effects Disease Modifying Therapy With Subcutaneous Interferon-b1b Patients With Multiple Sclerosis</brief_title>
	<detailed_description>Patient compliance disease modify treatment largely depend relatively common side effect treatment fatigue . Regular exercise potentially improve side effect . However , Safety effect exercise study patient multiple sclerosis . Our main aim study safety , tolerability effect exercise side effect subcutaneous interferon-b1b patient Multiple Sclerosis .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Recent diagnosis relapse remit multiple sclerosis treatment b1binterferon disease modify treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>b1b-interferon</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Exercise</keyword>
</DOC>